Protocol | Published:

Generation of human induced pluripotent stem cells from urine samples

Nature Protocols volume 7, pages 20802089 (2012) | Download Citation

Abstract

Human induced pluripotent stem cells (iPSCs) have been generated with varied efficiencies from multiple tissues. Yet, acquiring donor cells is, in most instances, an invasive procedure that requires laborious isolation. Here we present a detailed protocol for generating human iPSCs from exfoliated renal epithelial cells present in urine. This method is advantageous in many circumstances, as the isolation of urinary cells is simple (30 ml of urine are sufficient), cost-effective and universal (can be applied to any age, gender and race). Moreover, the entire procedure is reasonably quick—around 2 weeks for the urinary cell culture and 3–4 weeks for the reprogramming—and the yield of iPSC colonies is generally high—up to 4% using retroviral delivery of exogenous factors. Urinary iPSCs (UiPSCs) also show excellent differentiation potential, and thus represent a good choice for producing pluripotent cells from normal individuals or patients with genetic diseases, including those affecting the kidney.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).

  2. 2.

    & Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

  3. 3.

    et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).

  4. 4.

    et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010).

  5. 5.

    et al. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum. Mol. Genet. 20, 3176–3187 (2011).

  6. 6.

    et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008).

  7. 7.

    , , & Immunogenicity of induced pluripotent stem cells. Nature 474, 212–215 (2011).

  8. 8.

    et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68–73 (2011).

  9. 9.

    et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58–62 (2011).

  10. 10.

    et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63–67 (2011).

  11. 11.

    et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276–1284 (2008).

  12. 12.

    , , & Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502–3510 (2009).

  13. 13.

    et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71–79 (2010).

  14. 14.

    et al. Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc. Natl. Acad. Sci. USA 107, 3558–3563 (2010).

  15. 15.

    et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. USA 106, 15720–15725 (2009).

  16. 16.

    et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7, 15–19 (2010).

  17. 17.

    et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7, 11–14 (2010).

  18. 18.

    et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7, 20–24 (2010).

  19. 19.

    et al. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. J. Periodontal. Res. 46, 438–447 (2011).

  20. 20.

    et al. Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649–643 (2009).

  21. 21.

    , , , & Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 51, 1810–1819 (2010).

  22. 22.

    et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum. Mol. Genet. 18, 4340–4349 (2009).

  23. 23.

    et al. Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Hum. Mol. Genet. 21, 32–45 (2012).

  24. 24.

    et al. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J. Biol. Chem. 285, 11227–11234 (2010).

  25. 25.

    et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353–357 (2009).

  26. 26.

    et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434–441 (2009).

  27. 27.

    , & Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat. Protoc. 7, 718–728 (2012).

  28. 28.

    & Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat. Protoc. 5, 371–382 (2010).

  29. 29.

    et al. Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat. Protoc. 5, 811–820 (2010).

  30. 30.

    Are renal proximal tubular epithelial cells constantly prepared for an emergency? Focus on 'the proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells'. Am. J. Physiol. Cell Physiol. 294, C1–C3 (2008).

  31. 31.

    Anatomy of the urinary tract. in The Netter Collection of Medical Illustrations: Urinary System 2nd edn., Vol. 5 (eds. Christopher, R. & Kelly J.L.) 2–28 (Saunders, 2012).

  32. 32.

    et al. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 54, 3427–3434 (2005).

  33. 33.

    & Culture of cells from the urine of newborn children. Nature 239, 231 (1972).

  34. 34.

    Culture of cells from the urine and bladder washings of adults. Somatic Cell Genet. 2, 281–283 (1976).

  35. 35.

    Culture of urinary cells. Birth Defects Orig. Artic. Ser. 16, 85–93 (1980).

  36. 36.

    , & Short-term culture of epithelial cells from urine of adults. Proc. Soc. Exp. Biol. Med. 161, 153–157 (1979).

  37. 37.

    & Urinary tract epithelial cells cultured from human urine. Int. Rev. Cytol. Suppl. 11–23 (1979).

  38. 38.

    & Human newborn urine as a source of epithelial cells. Birth Defects Orig. Artic. Ser. 16, 231–237 (1980).

  39. 39.

    , & Human epithelial cells cultured from urine: growth properties and keratin staining. In Vitro 16, 866–874 (1980).

  40. 40.

    et al. Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch. Toxicol. 74, 618–626 (2000).

  41. 41.

    et al. Urine-derived cells are a potential source for urological tissue reconstruction. J. Urol. 180, 2226–2233 (2008).

  42. 42.

    et al. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng. Part A 17, 2123–2132 (2011).

  43. 43.

    et al. Generation of induced pluripotent stem cells from urine. J. Am. Soc. Nephrol. 22, 1221–1228 (2011).

  44. 44.

    et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010).

  45. 45.

    , , & Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Technical note. Kidney Int. 52, 1321–1331 (1997).

  46. 46.

    , & Flow cytometric immunodissection of the human distal tubule and cortical collecting duct system. Kidney Int. 59, 554–564 (2001).

  47. 47.

    , , , & Generation of human induced pluripotent stem cells. Nat. Protoc. 3, 1180–1186 (2008).

  48. 48.

    , , , & Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection. Nat. Protoc. 6, 701–714 (2011).

  49. 49.

    & Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. Nat. Protoc. 6, 1251–1273 (2011).

  50. 50.

    et al. Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells Dev. 19, 1637–1648 (2010).

  51. 51.

    et al. Generation of induced pluripotent stem cells from human kidney mesangial cells. J. Am. Soc. Nephrol. 22, 1213–1220 (2011).

  52. 52.

    et al. Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, Oct4 and Sox2. J. Biol. Chem. 287, 24131–24138 (2012).

  53. 53.

    et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009).

  54. 54.

    et al. Mouse meningiocytes express Sox2 and yield high efficiency of chimeras after nuclear reprogramming with exogenous factors. J. Biol. Chem. 283, 33730–33735 (2008).

  55. 55.

    et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267–280 (2011).

Download references

Acknowledgements

This work was funded by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020106), the National Natural Science Foundation of China (31071309), the Ministry of Science and Technology of China 973 program (2011CB965200), the Hong Kong Research Grant Council Collaborative Research Grant (HKU8/CRF/09), Theme Based Research Scheme (T12-705/11), General Research Fund (HKU 780110M), Austrian Science Fund (S93-06) and Genome Research Austria (GEN-AU 820982).

Author information

Author notes

    • Ting Zhou
    •  & Christina Benda

    These authors contributed equally to this work.

Affiliations

  1. Key Laboratory of Regenerative Biology, Chinese Academy of Sciences, and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Guangzhou, China.

    • Ting Zhou
    • , Christina Benda
    • , Yinghua Huang
    • , Jiayin Yang
    • , Yu Wang
    • , Ya Zhang
    • , Qiang Zhuang
    • , Yanhua Li
    • , Xichen Bao
    • , Duanqing Pei
    •  & Miguel A Esteban
  2. Aging and Immortalization Research, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.

    • Sarah Dunzinger
    • , Johannes Grillari
    •  & Regina Grillari-Voglauer
  3. Cardiology Division, Department of Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.

    • Jenny Cy Ho
    •  & Hung-Fat Tse
  4. Guangdong Stem Cell and Regenerative Medicine Research Centre, University of Hong Kong, Hong Kong.

    • Hung-Fat Tse
    •  & Miguel A Esteban
  5. Guangzhou Institutes of Biomedicine and Health, Guangzhou, China.

    • Hung-Fat Tse
    •  & Miguel A Esteban
  6. Evercyte, Vienna, Austria.

    • Johannes Grillari
    •  & Regina Grillari-Voglauer

Authors

  1. Search for Ting Zhou in:

  2. Search for Christina Benda in:

  3. Search for Sarah Dunzinger in:

  4. Search for Yinghua Huang in:

  5. Search for Jenny Cy Ho in:

  6. Search for Jiayin Yang in:

  7. Search for Yu Wang in:

  8. Search for Ya Zhang in:

  9. Search for Qiang Zhuang in:

  10. Search for Yanhua Li in:

  11. Search for Xichen Bao in:

  12. Search for Hung-Fat Tse in:

  13. Search for Johannes Grillari in:

  14. Search for Regina Grillari-Voglauer in:

  15. Search for Duanqing Pei in:

  16. Search for Miguel A Esteban in:

Contributions

M.A.E., J.G. and R.G.-V. conceived the original idea. M.A.E., T.Z., C.B. and S.D. devised the protocol. J.G. and R.G.-V. provided advice for urinary cell isolation. T.Z., C.B. and S.D. performed most of the experiments. Y.H. and Y.L. contributed to these experiments. J.C.H., J.Y., Y.W., Y.Z., Q.Z. and X.B. contributed to the more recent adaptations of the protocol and participated in patient-specific UiPSC generation. M.A.E. supervised the experiments. M.A.E., H.-F.T., J.G. and R.G.-V. provided financial support. D.P. provided infrastructure support. M.A.E., T.Z. and C.B. wrote the manuscript and approved the final version.

Competing interests

J.G. and R.G.V. are cofounders and directors of Evercyte.

Corresponding author

Correspondence to Miguel A Esteban.

Supplementary information

PDF files

  1. 1.

    Supplementary Figure 1

    Collection and isolation of urinary cells. 30-200 ml of urine can be collected with a disposable container. Urine samples are then transferred to 50 ml tubes and centrifuged. The pellets are resuspended and pooled into a single 50 ml tube. Cells are then washed carefully and transferred to a single well of a 12-well plate in primary medium. Urinary cell colonies routinely appear within the first 4 days of culture.

  2. 2.

    Supplementary Table 1

    Urinary cell collection and UiPSC generation in our laboratories. F: Female; M: Male; SCN5A: Sodium channel protein type 5 subunit alpha; LMNA: Lamin A/C; LAMP2: Lysosomal-associated membrane protein 2; LDLR: Low density lipoprotein receptor.

  3. 3.

    Supplementary Table 2

    Characterization of urinary cells. The expression of all the listed markers was detected by qPCR and/or immunofluorescence, as previously reported1. UC = urinary cells, RPTECs = renal proximal tubular epithelial cells. No expression = -, low expression = +, high expression = ++, very high expression = +++.

  4. 4.

    Supplemenatry Table 3

    Tools for characterization of urinary cells. NR3C2, L1CAM and SLC2A1 in panel b are renal epithelial markers.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nprot.2012.115

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.